FindTrial
Sign In

COMMON DISEASES IN LIVER FAILIURE PATIENTS AND ITS DRUG USE PATTERN

PREVALENCE OF COMORBIDITIES AND DRUG UTILIZATION PATTERN IN HEPATIC IMPAIRMENT PATIENTS AT A TERTIARY CARE HOSPITAL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/02/017459
Enrollment
200
Registered
2019-02-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: K769- Liver disease, unspecified Health Condition 3: K77- Liver disorders in diseases classified elsewhere

Interventions

None listed

Sponsors

NITTE DEEMED TO BE UNIVERSITY
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patient who are diagnosed with any hepatic impairment. 2)Patient of age more than 18years and either sex 3)Patient who give the consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1)Pregnant women 2)Out patients 3)Patient who donâ??t give consent to participate in the study

Design outcomes

Secondary

MeasureTime frame
â?¢ Understand the significance of involvement of social habits in hepatic impairment patients.Timepoint: Single point—

Primary

MeasureTime frame
â?¢Evaluation of drug use pattern in hepatic impairment patients â?¢Identify the prevalent co-morbid conditions prevalent in hepatic impairment patients Timepoint: Single point—

Countries

India

Contacts

Public ContactRISHAB P

NITTE GULABI SHETTY MEMORIAL INSTITUTE OF PHARMACEUTICAL SCIENCES

bharathraj@nitte.edu.in9035948490

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026